Northwest Biotherapeutics entered into a Stock Purchase Agreement with SIO Capital Management for the purchase of 8,125,000 shares of common stock at $0.40 per share, with gross proceeds of $3,250,000.
AI Assistant
Northwest Biotherapeutics Inc
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.